| Literature DB >> 24688731 |
Shu-Yun Tung1, Kuan-Wei Lee2, Jia-Yang Hong2, Sue-Ping Lee1, Hsiao-Hsuian Shen3, Gunn-Guang Liou4.
Abstract
In budding yeast, the Sir2, Sir3 and Sir4 proteins form SIR complexes, required for the assembly of silent heterochromatin domains, and which mediate transcription silencing at the telomeres as well as at silent mating type loci. In this study, under fluorescence microscopy, we found most Sir3-GFP expressions in the logarithmic phase cells appeared as multiple punctations as expected. However, some differences in the distribution of fluorescent signals were detected in the diauxic~early stationary phase cells. To clarify these, we then used ChIP on chip assays to investigate the genome-wide localization of Sir3. In general, Sir3 binds to all 32 telomere proximal regions, the silent mating type loci and also binds to the rDNA region. However, the genome-wide localization patterns of Sir3 are different between these two distinct growth phases. We also confirmed that Sir3 binds to a recently identified secondary binding site, PAU genes, and further identified 349 Sir3-associated cluster regions. These results provide additional support in roles for Sir3 in the modulation of gene expression during physical conditions such as diauxic~early stationary phase growing. Moreover, they imply that Sir3 may be not only involved in the formation of conventional silent heterochromatin, but also able to associate with some other chromatin regions involved in epigenetic regulation.Entities:
Keywords: ChIP on chip; Sir3; genome-wide; heterochromatin
Year: 2013 PMID: 24688731 PMCID: PMC3962127 DOI: 10.5936/csbj.201304001
Source DB: PubMed Journal: Comput Struct Biotechnol J ISSN: 2001-0370 Impact factor: 7.271
Figure 1Sir3-GFP localization in cells at two different growth stages. (A) The photographs of cells: are differential interference contrast (DIC)/Nomarski images (upper-left panel), GFP fluorescence image (upper-right panel), stained with DAPI (lower-left panel) and merged image (lower-right panel). The inserted white-framed box is enlarged from the small white-framed boxed area and only shows fluorescence signals. (B) is the same as (A) except cells were grown to diauxic~early stationary phase instead of taken at logarithmic phase. The weaker and smaller fluorescence signals (double-headed arrow) and the less focused fluorescence signals close to the obvious higher intensity foci (arrows) are indicated.
Figure 2The relative amounts of Sir3 in cells at the two different growth stages. (A) Western blots of Sir3 were detected with Sir3-GFP and Sir3-Myc strains cells at the logarithmic and diauxic~early stationary phases respectively, as indicated. Actin was used as internal control and for normalization of signal. (B) The quantified results from (A) were statistically analysis and plotted as a graph. Log: logarithmic phase; Sta: diauxic~early stationary phase.
Figure 3Genome-wide distribution of Sir3. Chromosomal display of Sir3 association patterns on the telomeric regions is shown. For each chromosome, the data from diauxic~early stationary phase (Sta) and logarithmic phase (Log) cells are shown on upper and lower panels, respectively, and are presented for the 15 kb region from the left (L) and right (R) chromosome ends. Chromosome number is indicated.
Figure 4Distribution map of Sir3. (A) Different distributions of Sir3 signals in diauxic~early stationary phase (Sta) and logarithmic phase (Log) cells for the whole of Chromosome 1. Relative ratio of enrichment signal (log2) is indicated. (B) Different distributions of Sir3 signals in two growth stages (Sta & Log) cells for the rDNA region of Chromosome 12. Relative ratio of enrichment signal (log2) is indicated. (C) The moving average of Sir3 binding at all 32 yeast telomeres was plotted as a functional parameter of distance from the chromosome end. Sir3 enrichment is measured as the Log2 score of IP versus input. Data is given for Sir3 binding in diauxic~early stationary phase (Sta, green) and logarithmic phase (Log, blue).
Figure 5Association regions of Sir3. (A) Sir3 associates on the regions of the PAU genes at different growth phases. The different distributions of the Sir3 signal at diauxic~early stationary (Sta) and logarithmic (Log) phases, the relative ratio of Sir3 enrichment signal (log2) and the related open reading frame (ORF) are indicated. (B) Enrichment signals of Sir3 show on the newly identified regions. For each Sir3-associated cluster region, the relative enriched ratio signal of diauxic~early stationary (Sta) and logarithmic (Log) phases are shown on the top panel and the third panel from the top, respectively. The related open reading frames (ORF) (fourth panel from the top) and their positions as detected by PCR (second panel from the top) are also indicated. The ChIP PCR and input DNA PCR results are shown on the fifth panel from top and bottom panel, respectively. The quantified relative ratios of ChIP PCR list as indicated. ACT1/Actin was used as internal control and for normalization of signal.
Ontological analysis of the genes located at Sir3 associated cluster regions.
| GO term | Association genes frequency | Function frequency |
|---|---|---|
| molecular function unknown | 228 out of 677 genes, 33.7% | 228 out of 1993 genes, 11.4% |
| DNA binding | 42 out of 677 genes, 6.2% | 42 out of 366 genes, 11.5% |
| oxidoreductase activity | 39 out of 677 genes, 5.8% | 39 out of 276 genes, 14.1% |
| transmembrane transporter activity | 31 out of 677 genes, 4.6% | 31 out of 308 genes, 10.1% |
| structural molecule activity | 28 out of 677 genes, 4.1% | 28 out of 356 genes, 7.9% |
| RNA binding | 28 out of 677 genes, 4.1% | 28 out of 753 genes, 3.7% |
| ATPase activity | 26 out of 677 genes, 3.8% | 26 out of 230 genes, 11.3% |
| kinase activity | 25 out of 677 genes, 3.7% | 25 out of 199 genes, 12.6% |
| nucleic acid binding transcription factor activity | 23 out of 677 genes, 3.4% | 23 out of 147 genes, 15.6% |
| ligase activity | 22 out of 677 genes, 3.2% | 22 out of 181 genes, 12.2% |
| transferase activity, transferring acyl groups | 21 out of 677 genes, 3.1% | 21 out of 116 genes, 18.1% |
| enzyme regulator activity | 21 out of 677 genes, 3.1% | 21 out of 219 genes, 9.6% |
| protein binding transcription factor activity | 17 out of 677 genes, 2.5% | 17 out of 124 genes, 13.7% |
| mRNA binding | 15 out of 677 genes, 2.2% | 15 out of 68 genes, 22.1% |
| lyase activity | 13 out of 677 genes, 1.9% | 13 out of 84 genes, 15.5% |
| transcription factor binding | 12 out of 677 genes, 1.8% | 12 out of 58 genes, 20.7% |
| peptidase activity | 11 out of 677 genes, 1.6% | 11 out of 137 genes, 8.0% |
| methyltransferase activity | 11 out of 677 genes, 1.6% | 11 out of 90 genes, 12.2% |
| hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds | 11 out of 677 genes, 1.6% | 11 out of 61 genes, 18.0% |
| phosphatase activity | 11 out of 677 genes, 1.6% | 11 out of 95 genes, 11.6% |
| small conjugating protein binding | 10 out of 677 genes, 1.5% | 10 out of 43 genes, 23.3% |
| cytoskeletal protein binding | 9 out of 677 genes, 1.3% | 9 out of 64 genes, 14.1% |
| histone binding | 9 out of 677 genes, 1.3% | 9 out of 39 genes, 23.1% |
| isomerase activity | 8 out of 677 genes, 1.2% | 8 out of 58 genes, 13.8% |
| lipid binding | 8 out of 677 genes, 1.2% | 8 out of 90 genes, 8.9% |
| transferase activity, transferring glycosyl groups | 8 out of 677 genes, 1.2% | 8 out of 100 genes, 8.0% |
| structural constituent of ribosome | 7 out of 677 genes, 1.0% | 7 out of 224 genes, 3.1% |
| protein binding, bridging | 7 out of 677 genes, 1.0% | 7 out of 43 genes, 16.3% |
| signal transducer activity | 7 out of 677 genes, 1.0% | 7 out of 40 genes, 17.5% |
| unfolded protein binding | 7 out of 677 genes, 1.0% | 7 out of 66 genes, 10.6% |
| nuclease activity | 5 out of 677 genes, 0.7% | 5 out of 131 genes, 3.8% |
| GTPase activity | 5 out of 677 genes, 0.7% | 5 out of 58 genes, 8.6% |
| enzyme binding | 4 out of 677 genes, 0.6% | 4 out of 49 genes, 8.2% |
| transferase activity, transferring alkyl or aryl (other than methyl) groups | 4 out of 677 genes, 0.6% | 4 out of 39 genes, 10.3% |
| helicase activity | 4 out of 677 genes, 0.6% | 4 out of 80 genes, 5.0% |
| protein transporter activity | 4 out of 677 genes, 0.6% | 4 out of 51 genes, 7.8% |
| translation factor activity, nucleic acid binding | 3 out of 677 genes, 0.4% | 3 out of 44 genes, 6.8% |
| hydrolase activity, acting on glycosyl bonds | 3 out of 677 genes, 0.4% | 3 out of 47 genes, 6.4% |
| ion binding | 3 out of 677 genes, 0.4% | 3 out of 45 genes, 6.7% |
| nucleotidyltransferase activity | 2 out of 677 genes, 0.3% | 2 out of 113 genes, 1.8% |
| rRNA binding | 0 out of 677 genes, 0% | 0 out of 92 genes, 0% |
| triplet codon-amino acid adaptor activity | 0 out of 677 genes, 0% | 0 out of 299 genes, 0% |
| RNA modification guide activity | 0 out of 677 genes, 0% | 0 out of 71 genes, 0% |
| other | 52 out of 677 genes, 7.7% | |
| not_yet_annotated | 2 out of 677 genes, 0.3% |